Reproduction of epstein-barr virus infection and pathogenesis in humanized mice

Shigeyoshi Fujiwara1

  • 1Department of Infectious Diseases, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Immune Network
|March 8, 2014
PubMed

Insights

Humanized mice offer a new model for studying Epstein-Barr virus (EBV) infection and diseases. This research explores EBV replication and pathogenesis in these advanced mouse models.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Epstein-Barr virus (EBV) causes various diseases, including lymphomas and autoimmune conditions.
  • A lack of suitable animal models has hindered the development of EBV therapies and vaccines.
  • EBV primarily infects humans, with limited susceptibility in non-human primates.

Purpose of the Study:

  • To review the development and application of humanized mice for studying EBV infection.
  • To evaluate the utility of humanized mice in modeling EBV pathogenesis.
  • To summarize recent findings on EBV reproduction in humanized mice.

Main Methods:

  • Utilizing severely immunodeficient mouse strains engrafted with human immune system components.
  • Reconstituting functional human immune systems in mice to mimic human responses.
  • Infecting humanized mice with EBV to study viral replication and disease progression.

Main Results:

  • Humanized mice successfully support EBV infection, mirroring aspects of human infection.
  • The model allows for the study of EBV's impact on human immune cells.
  • Pathogenesis of EBV-associated conditions can be investigated in this model.

Conclusions:

  • Humanized mice represent a significant advancement for EBV research.
  • This model is crucial for evaluating novel EBV therapies and vaccines.
  • Further studies in humanized mice will enhance understanding of EBV-associated diseases.

Related Concept Videos